Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors

Use of high-dose glucocorticoids for coronavirus disease 2019 (COVID-19; caused by SARS-CoV-2) is controversial because of safety concerns. We examined long-term consequences in severe acute respiratory syndrome (SARS; caused by SARS-CoV-1) survivors. Results showed that high-dose glucocorticoids gr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Sing, Chor-Wing, Tan, Kathryn C B, Wong, Ian C K, Cheung, Bernard M Y, Cheung, Ching-Lung
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7454482/
https://ncbi.nlm.nih.gov/pubmed/32671407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa992
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars